[Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
D000241:Adenosine / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000627:therapeutic use; D010101:Oxygen Consumption; D010869:Pindolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D011433:Propranolol; D010869:Pindolol; D000241:Adenosine; D010100:Oxygen
Die pharmakodynamischen Grundlagen einer spezifischen Therapie der koronarinsuffizienz.